NetworkNewsBreaks

WednesdayMar 11, 2020 1:26 pm

NetworkNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Trading Volume Rapidly Surged During First Four Days of Trading

InsuraGuest Technologies (TSX.V: ISGI) is a SaaS (Software-as-a-Service) company and the developer of the proprietary InsurTech platform designed to deliver insurance products to the hotel and vacation-rental market. On Friday, February 28 the company’s common shares began trading on the TSX Venture Exchange (“TSX.V”) under the symbol “ISGI”. According to an article on the company’s website titled ‘InsuraGuest Technologies Inc. Goes Public, Sees Trading Volume and Price Rise’, ISGI opened with a trading volume of 2,000 shares at $0.40 each. The price declined slightly before quickly climbing again, as the trading volume surged substantially to over 200,000 shares throughout the…

Continue Reading

WednesdayMar 11, 2020 11:54 am

NetworkNewsBreaks – Nikola Corp. and VectoIQ Acquisition Corp. (NASDAQ: VTIQ) to Create NASDAQ-Listed Company Focused on Next Gen Smart Transportation

Nikola Corporation, a leader in the design and development of BEV and FCEV class 8 semi-trucks, along with VectoIQ Acquisition Corp. (NASDAQ: VTIQ), a publicly-traded special purpose acquisition company, recently announced entry into a definitive agreement to create a company focused on the development of next generation smart transportation. Per the update, the combined company will be named Nikola Corporation and expected to remain NASDAQ-listed under the new ticker symbol "NKLA" upon the closing of the transaction. “In our two-year quest to find a partner that was a proven technology leader and focused on making a global difference, Nikola was…

Continue Reading

WednesdayMar 11, 2020 11:48 am

NetworkNewsBreaks – Aytu BioScience, Inc. (NASDAQ: AYTU) Enters Exclusive US Distribution Agreement for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test

Aytu BioScience (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced its entry into an exclusive distribution agreement for the right to commercialize a clinically validated and commercially used coronavirus 2019 (COVID-19) IgG/IgM Rapid Test. According to the update, the test has been licensed from L.B. Resources, Limited (a Hong Kong Corporation), which licensed North American rights from product developer Zhejiang Orient Gene Biotech Co., Ltd. The test, intended for professional use, delivers clinical results between 2 and 10 minutes at the point-of-care. The agreement grants Aytu the exclusive right to…

Continue Reading

WednesdayMar 11, 2020 10:56 am

NetworkNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Secures US Patent for “Interactive System Based on Light Intensity Recognition”

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced the United States Patent and Trademark Office’s issuance of U.S. patent number US 10,512,836 B2, covering Blue Hat's “Interactive System Based on Light Intensity Recognition.” According to the update, the Blue Hat system connects a physical toy with the virtual content of a mobile game, which the Company believes represents a major breakthrough in the realization of AR technology. Blue Hat's AR Racer product is a prominent example of the potential presented by…

Continue Reading

WednesdayMar 11, 2020 10:51 am

NetworkNewsBreaks – MCTC Holdings, Inc. (MCTC) Begins Organization of Animal Study Focused on THC-V and Appetite Suppression, Weight Loss

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, seeks to answer a pressing question within the cannabinoid industry arena: Does tetrahydrocannabivarin (“THC-V”) promote weight loss? According to the update, MCTC has completed Phase One of its Project Varin, a program designed to develop delivery systems and uses for THC-V, and is moving into its second phase of research. Company researchers are now organizing what is believed to be the industry's first animal study specifically focused on determining if the administration of THC-V leads to appetite suppression and/or weight loss. “While many…

Continue Reading

WednesdayMar 11, 2020 10:09 am

NetworkNewsBreaks – Sharing Services Global Corporation (SHRG) Reaches Amicable Agreement on Legal Disputes

Sharing Services Global Corporation (OTCQB: SHRG), formerly Sharing Services Inc., (and its subsidiaries) along with Robert Oblon, Jordan Brock and Alchemist Holdings, LLC, on Tuesday announced that, effective March 10, 2020, the foregoing parties have reached an amicable agreement concerning all disputes pending between them (including all litigation matters). According to the update, an executed comprehensive settlement agreement provides for the complete resolution of all disputes and further envisions a constructive relationship between all the parties on a go forward basis. Additional information is contained in SHRG’s 10-Q and 10-K filings with the Securities and Exchange Commission. To view the…

Continue Reading

WednesdayMar 11, 2020 9:36 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Announces Q4, Year End 2019 Financial Results

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, on Tuesday released its results for the fourth quarter and fiscal year ended December 31, 2019. Among the highlights, the company posted $3.25 million in quarterly revenue ($11.16 million for the year) consisting of hemp-derived product sales in Europe of $2.56 million ($9.88 million for the year) and sales from cannabis products in Canada of $0.69 million ($1.28 million for the year). “While 2019 was a challenging year for the entire sector, we have made significant progress on the operational front and adjusted our…

Continue Reading

WednesdayMar 11, 2020 9:17 am

NetworkNewsBreaks – Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) Grants Incentive Stock Options

Exro Technologies (CSE: XRO) (OTCQB: EXROF) on Tuesday announced that the company has granted incentive stock options to some directors, officers, employees, and consultants to purchase a total of 735,000 EXROF shares at a price of $0.375 each, in accordance with the company’s stock option plan. All the options are subject to vesting provisions, and all shares issued through the exercise of an option will be subject to a four month and one day hold period from the date of grant. To view the full press release, visit http://nnw.fm/0BsyB About Exro Technologies Inc. Exro facilitates the transition to clean energy…

Continue Reading

TuesdayMar 10, 2020 12:33 pm

NetworkNewsBreaks – Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) Announces Resignation of Executive Officer and Director

Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) on Monday announced that, effective March 9, 2020, Norman Tsui has resigned as its executive vice president, interim chief financial officer, corporate secretary and as a director of the Company. As a result, Wonderfilm is working to identify suitable candidates to replace Tsui. The Company thanks Mr. Tsui for his contributions, especially with regard to stepping in as the interim chief financial officer and working to resolve the Cease Trade Order against the Company, and wishes him well in his future endeavors. To view the full press release, visit http://nnw.fm/9dtLD About Wonderfilm Media…

Continue Reading

TuesdayMar 10, 2020 12:20 pm

NetworkNewsBreaks – CytoSorbents Corporation (NASDAQ: CTSO) Featured in Dawson James Research Report

CytoSorbents Corporation (NASDAQ: CTSO) was featured in a recent Institutional Research Report published by Dawson James Securities Inc. The report reads, “The company reported Q4 Revenues of $7.4M, $6.6M in cartridges vs. $5.7M in the prior qtr. Slow but steady growth, however we see the potential for revenues to rise with new indications. In fact, we believe CytoSorb sales have just scratched the surface of what’s possible. We are raising our price target from $15.00 to $17.00 per share.” To request access to the full report, visit http://nnw.fm/SB1bo About CytoSorbents Corporation CytoSorbents Corporation is a leader in critical care immunotherapy, specializing…

Continue Reading